Summary by Futu AI
On December 20, 2024, multiple GSK directors and executives executed significant share purchases on both London Stock Exchange and NYSE. Senior Independent Non-Executive Director Charles Bancroft made the largest purchase of 2,184 ADSs at $33.8097 per share, while Lady Susan Symonds, PCA of Non-Executive Chair, acquired 1,500 ordinary shares at £13.1508.Other notable transactions included Independent Non-Executive Director Dr. Vishal Sikka's purchase of 937 ADSs, and Wendy Becker's acquisition of 546 ordinary shares at £13.1900. Multiple board members, including Dr. Hal Barron, Dr. Anne Beal, Dr. Hal Dietz, Dr. Jesse Goodman, and Dr. Jeannie Lee, each purchased 271-272 ADSs at $33.8097 per share.
Comment(0)
Reason For Report